Excellence in Scientific Discovery

The Institute's comprehensive investigations extend from the earliest phase of basic discovery to the development of new cancer diagnostics, treatment protocols and prevention strategies

  • Research Programs

    Basic, clinical and translational studies into the biology of cancer and the factors that contribute to its onset and growth.

  • Shared Resources

    SCI provides expert support services and state-of-the-art equipment to all its members through a number of core facilities

  • Funding Opportunities

    Internal and external sources of support for cancer research, training and career development

Key Initiatives

In addition to the six research programs identified in our Cancer Center Support Grant, the Stanford Cancer Institute supports a number of key initiatives designed to foster discovery, application and translation of scientific knowledge. Inter-disciplinary teams of collaborative investigators partner to solve some of the most challenging questions in cancer research. Some of our key initiatives include:

Early Drug Development Program

The program aims to advance cancer treatment through early-phase clinical trials for solid tumors. It offers patients access to innovative therapies that extend beyond standard treatments and conducts research to determine the safety and efficacy of new drugs.

Learn More

The Stanford Brain Metastases Consortium

The Stanford Brain Metastases Consortium is a unique partnership between scientists, physicians and surgeons from across the Stanford community, bringing together experts in research and clinical care of brain metastases. The goal of the Consortium is to increase the number of available clinical trials and collaborative publications, and to enhance patients' experience through a team-based approach to care.

Learn More

Wipe Out Melanoma - California

Wipe Out Melanoma - California is a project focused on primary and secondary prevention research with a particular emphasis on Hispanic and low socioeconomic status Caucasian groups who are at the highest risk for advanced disease. It is a joint partnership with Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai, and part of a larger nationwide War on Melanoma- Federation of States.

Learn More
image
Clinical Trials for Rare Cancers

Nasopharyngeal Cancer Program

The SCI offers specialized expertise in clinical trials for multiple rare cancers, including nasopharyngeal cancer. 

 

Learn More

After Cancer: Stanford Cancer Survivorship Program

After Cancer's mission is  to improve the experience, and outcomes, of patients and caregivers throughout all phases of their cancer journey by advancing survivorship research, clinical care and education. 

Learn More